Possible Pathway to New Therapy for Alzheimer’s Disease

February 26, 2019 - Boston, MA, USA – Researchers have uncovered an enzyme and a biochemical pathway they believe may lead to the identification of drugs that could inhibit the production of beta-amyloid protein, the toxic initiator of Alzheimer's disease (AD). More...

February 26, 2019

Exercise Can Improve Non-Motor Symptoms of Parkinson’s Disease

Researchers review evidence of the effect of exercise on non-motor symptoms of PD in the Journal of Parkinson's Disease

March 4, 2019 - Amsterdam, NL – Exercise has potential to improve non-motor as well as motor symptoms of Parkinson's disease (PD), including cognitive function, report investigators in a review published in the Journal of Parkinson's Disease. More...

March 4, 2019

Recent Advances in Spina Bifida Care Extend Life and Improve Quality of Life

Recent research on spina bifida provides new insights into how to manage the disorder and help patients transition to adulthood, reports the Journal of Pediatric Rehabilitation Medicine

February 27, 2019 - Amsterdam, NL – Spina bifida (myelomeningocele) is the most common, permanently disabling birth defect compatible with life. In a collection of articles, published in the Journal of Pediatric Rehabilitation Medicine, experts describe important advances made in the care of spina bifida patients that extend life and improve quality of life. More...

February 27, 2019

New Treatment Offers Potentially Promising Results for the Possibility of Slowing, Stopping, or Even Reversing Parkinson’s Disease

February 27, 2019 - Amsterdam, NL – A pioneering clinical trials program that delivered an experimental treatment directly to the brain offers hope that it may be possible to restore the cells damaged in Parkinson's disease. The study investigated whether boosting the levels of a naturally-occurring growth factor, Glial Cell Line Derived Neurotrophic Factor (GDNF), can regenerate dying dopamine brain cells in patients with Parkinson's and reverse their condition, something no existing treatment can do. Potentially promising results of the third arm of the trials, an open access open-label extension study, are reported in the Journal of Parkinson's Disease. More...

February 27, 2019